Cargando…

Neurofilament Proteins as Body Fluid Biomarkers of Neurodegeneration in Multiple Sclerosis

Biomarkers of axonal degeneration have the potential to improve our capacity to predict and monitor neurological outcome in multiple sclerosis (MS) patients. Neurofilament proteins, one of the major proteins expressed within neurons and axons, have been detected in cerebrospinal fluid and blood samp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gresle, Melissa M., Butzkueven, Helmut, Shaw, Gerry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2011
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195785/ https://www.ncbi.nlm.nih.gov/pubmed/22096635 http://dx.doi.org/10.1155/2011/315406

Ejemplares similares

Association of plasma levels of Protein S with disease severity in multiple sclerosis
por: Ma, Gerry ZM, et al.
Publicado: (2015)

Depression and anxiety disorders in patients with multiple sclerosis: association with neurodegeneration and neurofilaments
por: Tauil, C.B., et al.
Publicado: (2021)

The potential of serum neurofilament as biomarker for multiple sclerosis
por: Bittner, Stefan, et al.
Publicado: (2021)

Serum neurofilament light as a biomarker in progressive multiple sclerosis
por: Kapoor, Raju, et al.
Publicado: (2020)

Neurofilament light chain as a biomarker for diagnosis of multiple sclerosis
por: Kouchaki, Ebrahim, et al.
Publicado: (2021)

Serum-Based Biomarkers in Neurodegeneration and Multiple Sclerosis
por: LoPresti, Patrizia
Publicado: (2022)

Neurofilament Light Chain as a Biomarker in Multiple Sclerosis
por: Varhaug, Kristin N., et al.
Publicado: (2019)

Antibodies to neurofilament light as potential biomarkers in multiple sclerosis
por: Puentes, Fabiola, et al.
Publicado: (2021)

Uman-type neurofilament light antibodies are effective reagents for the imaging of neurodegeneration
por: Shaw, Gerry, et al.
Publicado: (2023)

Neurofilament Light Chain Is a Biomarker of Neurodegeneration in Ataxia Telangiectasia
por: Donath, H., et al.
Publicado: (2021)

Neurofilament light as a blood biomarker for neurodegeneration in Down syndrome
por: Strydom, Andre, et al.
Publicado: (2018)

Neurodegeneration in multiple sclerosis
por: Mey, Gabrielle M., et al.
Publicado: (2022)

Emerging Biomarkers of Multiple Sclerosis in the Blood and the CSF: A Focus on Neurofilaments and Therapeutic Considerations
por: Biernacki, Tamás, et al.
Publicado: (2022)

Neurofilaments in progressive multiple sclerosis: a systematic review
por: Williams, Thomas, et al.
Publicado: (2020)

Comparative Analysis of Neurodegeneration and Axonal Dysfunction Biomarkers in the Cerebrospinal Fluid of Patients with Multiple Sclerosis
por: Kulczyńska-Przybik, Agnieszka, et al.
Publicado: (2022)

Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis
por: Disanto, Giulio, et al.
Publicado: (2017)

The effect of lumbar puncture on the neurodegeneration biomarker neurofilament light in macaque monkeys
por: Boehnke, Susan E., et al.
Publicado: (2020)

Differential expression of neurofilament triplet proteins in brain development
por: Shaw, Gerry, et al.
Publicado: (1982)

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
por: Lewczuk, Piotr, et al.
Publicado: (2018)

Iron and Neurodegeneration in Multiple Sclerosis
por: Khalil, Michael, et al.
Publicado: (2011)

Blood and cerebrospinal fluid neurofilament light differentially detect neurodegeneration in early Alzheimer’s disease
por: Andersson, Emelie, et al.
Publicado: (2020)

Serum neurofilament light chain is a useful biomarker in pediatric multiple sclerosis
por: Reinert, Marie-Christine, et al.
Publicado: (2020)

Phosphorylated neurofilament heavy chain is a marker of neurodegeneration in Leber hereditary optic neuropathy (LHON)
por: Guy, John, et al.
Publicado: (2008)

The Evolution of Neurofilament Light Chain in Multiple Sclerosis
por: Ferreira-Atuesta, Carolina, et al.
Publicado: (2021)

Kynurenines and Neurofilament Light Chain in Multiple Sclerosis
por: Pukoli, Dániel, et al.
Publicado: (2021)

Plasma neurofilament light chain as a potential biomarker of neurodegeneration in murine brain
por: Sano, Tomoya, et al.
Publicado: (2023)

Cerebrospinal Fluid Neurofilament Light Chain Is Associated with Kynurenine Pathway Metabolite Changes in Multiple Sclerosis
por: Rajda, Cecilia, et al.
Publicado: (2020)

Tau as a fluid biomarker of concussion and neurodegeneration
por: Hossain, Iftakher, et al.
Publicado: (2022)

Neurodegeneration in multiple sclerosis involves multiple pathogenic mechanisms
por: Levin, Michael C, et al.
Publicado: (2014)

A Scoping Review on Body Fluid Biomarkers for Prognosis and Disease Activity in Patients with Multiple Sclerosis
por: Barizzone, Nadia, et al.
Publicado: (2022)

The importance of collecting structured clinical information on multiple sclerosis
por: Ziemssen, Tjalf, et al.
Publicado: (2016)

Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis
por: Byrne, Lauren M, et al.
Publicado: (2017)

Epigenetic differences at the HTR2A locus in progressive multiple sclerosis patients
por: Maltby, Vicki E., et al.
Publicado: (2020)

Neurofilament light chain as a potential biomarker for monitoring neurodegeneration in X-linked adrenoleukodystrophy
por: Weinhofer, Isabelle, et al.
Publicado: (2021)

What Do Effective Treatments for Multiple Sclerosis Tell Us about the Molecular Mechanisms Involved in Pathogenesis?
por: Buzzard, Katherine A., et al.
Publicado: (2012)

Retinal and Brain Microglia in Multiple Sclerosis and Neurodegeneration
por: Choi, Soyoung, et al.
Publicado: (2021)

Demographic and disease‐related factors impact on cerebrospinal fluid neurofilament light chain levels in multiple sclerosis
por: Zondra Revendova, Kamila, et al.
Publicado: (2022)

Neurofilament markers in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis
por: Shi, Jiaying, et al.
Publicado: (2021)

Response to mitogen‐activated protein kinase inhibition of neurodegeneration in Langerhans cell histiocytosis monitored by cerebrospinal fluid neurofilament light as a biomarker: a pilot study
por: Henter, Jan‐Inge, et al.
Publicado: (2021)

Monitoring disease activity in multiple sclerosis using serum neurofilament light protein
por: Novakova, Lenka, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8qek0vsmcq6if6ut70k5lll2lr